Antiretroviral Prophylaxis and the Risk of Cleft Lip and Palate: Preliminary Signal Detection in the Food and Drug Administration's Adverse Events Reporting System Database

Ahmad S.R. , Freiman J.P. , Graham D.J. , Nelson R.C. Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA. Pharmacoepidemiol Drug Saf. 1996; 5(1): 1–7.

Baker R. Safety alert issued on efavirenz (Sustiva). BETA. 1998; Apr: 6–7.

Banks D. , Woo E.J. , Burwen D.R. , Perucci P. , Braun M.M. , Ball R. Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf. 2005; 14: 601–609.

Ford N. , Mofenson L. , Kranzer K. , Medu L. , Frigati L. , Mills E.J. , Calmy A. Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts. AIDS. 2010; 24: 1461–1470.

Joao E.C. , Calvet G.A. , Krauss M.R. , Freimanis Hance L. , Ortiz J. , Ivalo S.A. , Pierre R. , Reyes M. , Heather Watts D. , Read J.S. , NISDI Perinatal Study Group. Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. J Acquir Immune Defic Syndr. 2010; 53: 176–185.

Kessler D.A. Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993; 269: 2765–2768.

Krapels I.P. , Vermeij-Keers C. , Múller M. , de Klein A. , Steegers-Theunissen R.P. Nutrition and genes in the development of orofacial clefting. Nutr Rev. 2006; 64: 280–288.

Loffredo L.C. , Souza J.M. , Freitas J.A. , Mossey P.A. Oral clefts and vitamin supplementation. Cleft Palate Craniofac J. 2001; 38: 76–83.

Rothman K.J. , Moore L.L. , Singer M.R. , Nguyen U.S. , Mannino S. , Milunsky A. Teratogenicity of high vitamin Aintake. N Engl J Med. 1995; 333: 1369–1373.

Szarfman A. , Machado S.G. , O'Neill R.T. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf. 2002; 25: 381–392.

Taylor G.P. , Low-Beer N. Antiretroviral therapy in pregnancy: a focus on safety. Drug Saf. 2001; 24: 683–702.

Townsend C.L. , Tookey P.A. , Cortina-Borja M. , Peckham C.S. Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003. J Acquir Immune Defic Syndr. 2006; 42: 91–94.

Townsend C.L. , Willey B.A. , Cortina-Borja M. , Peckham C.S. , Tookey P.A. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990–2007. AIDS. 2009; 23: 519–524.

Watts D.H. , Li D. , Handelsman E. , Tilson H. , Paul M. , Foca M. , Vajaranant M. , Diaz C. , Tuomala R. , Thompson B. Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr. 2007; 44: 299–305.

White A. , Eldridge R. , Andrews E. Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry. Acta Paediatr Suppl. 1997; 421: 86–88.

Wilson A.M. , Thabane L. , Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol. 2004; 57: 127–134.

Zucchero T.M. , Cooper M.E. , Maher B.S. , Daack-Hirsch S. , Nepomuceno B. , Ribeiro L. , Caprau D. , Christensen K. , Suzuki Y. , Machida J. . Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N Engl J Med. 2004; 351: 769–780.